Posted by Michael Wonder on 25 Oct 2021
Drug pricing reform opponents win most pharma lobbying money
26 October 2021 - Democratic Party law makers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry's push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows.
